Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assay

Masatoshi Wakui, Yoshifumi Uwamino, Yoko Yatabe, Terumichi Nakagawa, Akiko Sakai, Toshinobu Kurafuji, Ayako Shibata, Yukari Tomita, Masayo Noguchi, Akiko Tanabe, Tomoko Arai, Akemi Ohno, Hiromitsu Yokota, Shunsuke Uno, Wakako Yamasawa, Yasunori Sato, Mari Ikeda, Akihiko Yoshimura, Naoki Hasegawa, Hideyuki SayaMitsuru Murata

研究成果: Article査読

抄録

Memory T cell responses have been analyzed only in small cohorts of COVID-19 vaccines. Herein, we aimed to assess anti-SARS-CoV-2 cellular immunity in a large cohort using QuantiFERON assays, which are IFN-γ release assays (IGRAs) based on short-term whole blood culture. The study included 571 individuals receiving the viral spike (S) protein-expressing BNT162b2 mRNA vaccine. QuantiFERON assays revealed antigen-specific IFN-γ production in most individuals 8 weeks after the second dose. Simultaneous flow cytometric assays to detect T cells expressing activation-induced markers (AIMs) performed for 28 randomly selected individuals provided data correlating with the QuantiFERON data. Simultaneous IFN-γ enzyme-linked immunospot and AIM assays for another subset of 31 individuals, based on short-term peripheral blood mononuclear cell culture, also indicated a correlation between IFN-γ production and AIM positivity. These observations indicated the acquisition of T cell memory responses and supported the usability of IGRAs to assess cellular immunity. The QuantiFERON results were weakly correlated with serum IgG titers against the receptor-binding domain of the S protein and were associated with pre-vaccination infection and adverse reactions after the second dose. The present study revealed cellular immunity after COVID-19 vaccination, providing insights into the effects and adverse reactions of vaccination.

本文言語English
ページ(範囲)1961-1971
ページ数11
ジャーナルEuropean Journal of Immunology
52
12
DOI
出版ステータスPublished - 2022 12月

ASJC Scopus subject areas

  • 免疫アレルギー学
  • 免疫学

フィンガープリント

「Assessing anti-SARS-CoV-2 cellular immunity in 571 vaccines by using an IFN-γ release assay」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル